14th International HLA and Immunogenetics Workshop: Report on the structural basis of HLA compatibility

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 180-184

  Duquesnoy, R J ^a   Claas, F H J ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Eplet; Histocompatibility; HLA; HLAMatchmaker

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY;

ALLOIMMUNIZATION; CONFERENCE PAPER; DNA POLYMORPHISM; HISTOCOMPATIBILITY; HISTOINCOMPATIBILITY; HLA MATCHING; HLA SYSTEM; HUMAN; IMMUNOGENETICS; IMMUNOGENICITY; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGENETICS; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; TISSUE DONORS;

EID: 34247251540     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00766.x     Document Type: Conference Paper

References (14)

1. Duquesnoy RJ. HLA Matchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002: 63: 339-52.
2. Duquesnoy RJ, Witvliet MJ, Doxiadis IIN, de Fijter H, Claas FHJ. HLA Matchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates. Transpl Int 2004: 7: 31-8.
3. Claas FHJ, Witvliet M, Duquesnoy RJ, Persijn G, Doxiadis IIN. The acceptable mismatch program as a fast tool to transplant highly sensitized patients awaiting a post-mortal kidney: short waiting time and excellent graft outcome. Transplantation 2004: 78: 190-3.
4. Doxiadis IIN, Duquesnoy RJ, Claas HJ. Extending options for highly sensitized patients to receive a suitable kidney graft. Curr Opin Immunol 2005: 17: 536-40.
5. Duquesnoy R. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006: 67: 847-62.
6. Duquesnoy R, Mulder A, Askar M, Fernandez-Vina M, Claas F. HLA Matchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005: 66: 749-61.
7. Mohanakumar T, Waldrep JC, Phibbs M, Mendez-Picon G, Kaplan AM, Lee HM. Serological characterization of antibodies eluted from chronically rejected human renal allografts. Transplantation 1981: 32: 61-6.
8. Marcen R, Ting A, Taylor CJ, Miach PJ, Chapman JR, Morris PJ. Immunoglobulin class and specificity of lymphocytotoxic antibodies after kidney transplantation. Nephrol Dial Transplant 1988: 3: 809-13.
9. Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003: 76: 395-400.
10. Adeyi O, Girnita A, Howe J et al. Serum analysis after kidney transplant nephrectomy reveals restricted antibody specificity patterns against donor HLA class I antigens. Transpl Immunol 2005: 14: 53-62.
11. Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977: 2: 219-26.
12. Nambiar A, Duquesnoy RJ, Adams S et al. HLAMatchmaker-driven analysis of response to HLA matched platelet transfusions in alloimmunized patients. Blood 2006: 107: 1680-7.
13. Kallon D, Papassavas A, Brown C, Duquesnoy R, Ouwehand W, Navarrete C. The use HLA epitope mismatches for selection of platelets for transfusions in immunologically refractory patients. In press.
14. Duquesnoy RJ, Marrari M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 2002: 63: 353-63.